Updated Results Of A Phase 1B Study Of Ibrutinib (Ibr) Plus Obinutuzumab (Obin) In Patients With Relapsed Or Refractory (R/R) Chronic Lymphocytic Leukemia (Cll)
Ibrutinib;Obinutuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Updated Results Of A Phase 1B Study Of Ibrutinib (Ibr) Plus Obinutuzumab (Obin) In Patients With Relapsed Or Refractory (R/R) Chronic Lymphocytic Leukemia (Cll) ### Output: Ibrutinib;Obinutuzumab